The vaginal dilators market size has grown strongly in recent years. It will grow from $25.21 billion in 2025 to $27.39 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of pelvic floor disorders, rising awareness of post-surgical therapy, technological improvements in medical-grade silicone devices, growth in gynecological clinics, expanding focus on women’s sexual health.
The vaginal dilators market size is expected to see strong growth in the next few years. It will grow to $37.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to adoption of personalized and 3D-printed dilators, integration with mobile health apps, growth of telemedicine in gynecological care, increased demand for home-use therapy devices, rising awareness campaigns for pelvic floor rehabilitation. Major trends in the forecast period include 3d-printed customized dilators, ai-enabled therapy tracking, multi-size and multi-material devices, integration with telemedicine platforms, home-based pelvic floor therapy.
The growing prevalence of gynecological conditions is increasingly supporting the expansion of the vaginal dilators market going forward. Gynecological conditions refer to disorders, diseases, or medical issues affecting the female reproductive system. The prevalence of gynecological conditions is rising due to factors such as lifestyle changes, delayed childbearing, increased exposure to environmental toxins, and higher infection rates. Vaginal dilators serve as effective tools in managing gynecological conditions by helping reduce symptoms, support treatment outcomes, and improve overall quality of life for patients. For example, in October 2025, according to Cancer Australia, an Australia-based government agency, approximately 6,963 new cases of gynecological cancers were diagnosed in 2024, with estimates indicating that one in 23 women faces a lifetime risk of being diagnosed with a gynecological cancer by age 85. Consequently, the rising prevalence of gynecological conditions is contributing to growth in the vaginal dilators market.
Leading companies operating in the vaginal dilators market are focusing on innovative virtual clinical trials to evaluate device effectiveness, patient comfort, and long-term outcomes. Virtual clinical trials use decentralized, digital technologies to conduct research remotely. For example, in June 2024, Materna Medical Inc., a US-based women’s pelvic health company, launched the Prospective On-Market Patient-reported Outcomes for Milli Vaginal Dilator trial. This study aims to evaluate the effectiveness of the Milli Vaginal Dilator in reducing discomfort associated with vaginismus by collecting patient-reported outcomes through a remote trial model.
In August 2024, Owen Mumford, a UK-based medical device solutions company, acquired Empelvic for an undisclosed amount. Through this acquisition, Owen Mumford seeks to strategically enhance its pelvic and sexual health portfolio by incorporating Empelvic’s innovative technologies into its existing product range, which includes vaginal dilators and vacuum therapy devices. Empelvic is a Denmark-based company specializing in pelvic floor cushion technology and the manufacture of vaginal dilators.
Major companies operating in the vaginal dilators market are McKesson Corporation, Medline Industries LP, CooperSurgical Inc., MedGyn Products Inc., Femmax, CalExotics, GPC Medical Ltd., AvaCare Medical, Soul Source Inc., Panpac Medical Corporation, Velvi, Amielle, Intimate Rose, Hope&Her, Berman Center, NeuEve LLC, Dr. Berman's Dilators, Vuvatech Inc., Marina Medical Instruments Inc., Bien Aus Pty Ltd.
North America was the largest region in the vaginal dilators market in 2025. The regions covered in the vaginal dilators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vaginal dilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported silicone, plastic, and magnetic components used in vaginal dilators, raising production and retail prices across the market. These impacts are most evident in silicone and magnetic dilator segments, particularly in Asia-Pacific and Europe where many raw materials and finished products are sourced internationally. Higher prices have affected affordability for clinics and home use consumers. However, tariffs have also encouraged local manufacturing and sourcing of medical grade materials, supporting regional production and improving long term supply stability.
The vaginal dilators market research report is one of a series of new reports that provides vaginal dilators market statistics, including vaginal dilators industry global market size, regional shares, competitors with a vaginal dilators market share, detailed vaginal dilators market segments, market trends and opportunities, and any further data you may need to thrive in the vaginal dilators industry. This vaginal dilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vaginal dilators are therapeutic medical tools designed to gently widen the vaginal canal. They come in different sizes and shapes and are used under medical guidance to address specific health conditions and improve comfort.
The primary types of vaginal dilators include silicone vaginal dilators, magnetic vaginal dilators, and others. Silicone vaginal dilators are medical devices manufactured from soft and flexible silicone material and are intended to assist in the gradual stretching of vaginal tissues. These products are distributed through channels such as online platforms, retail pharmacies, and others and are used in applications across hospitals, clinics, and other healthcare settings.
The vaginal dilators market consists of sales of standard dilators, thermal dilators, and custom dilators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vaginal dilators market size is expected to see strong growth in the next few years. It will grow to $37.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to adoption of personalized and 3D-printed dilators, integration with mobile health apps, growth of telemedicine in gynecological care, increased demand for home-use therapy devices, rising awareness campaigns for pelvic floor rehabilitation. Major trends in the forecast period include 3d-printed customized dilators, ai-enabled therapy tracking, multi-size and multi-material devices, integration with telemedicine platforms, home-based pelvic floor therapy.
The growing prevalence of gynecological conditions is increasingly supporting the expansion of the vaginal dilators market going forward. Gynecological conditions refer to disorders, diseases, or medical issues affecting the female reproductive system. The prevalence of gynecological conditions is rising due to factors such as lifestyle changes, delayed childbearing, increased exposure to environmental toxins, and higher infection rates. Vaginal dilators serve as effective tools in managing gynecological conditions by helping reduce symptoms, support treatment outcomes, and improve overall quality of life for patients. For example, in October 2025, according to Cancer Australia, an Australia-based government agency, approximately 6,963 new cases of gynecological cancers were diagnosed in 2024, with estimates indicating that one in 23 women faces a lifetime risk of being diagnosed with a gynecological cancer by age 85. Consequently, the rising prevalence of gynecological conditions is contributing to growth in the vaginal dilators market.
Leading companies operating in the vaginal dilators market are focusing on innovative virtual clinical trials to evaluate device effectiveness, patient comfort, and long-term outcomes. Virtual clinical trials use decentralized, digital technologies to conduct research remotely. For example, in June 2024, Materna Medical Inc., a US-based women’s pelvic health company, launched the Prospective On-Market Patient-reported Outcomes for Milli Vaginal Dilator trial. This study aims to evaluate the effectiveness of the Milli Vaginal Dilator in reducing discomfort associated with vaginismus by collecting patient-reported outcomes through a remote trial model.
In August 2024, Owen Mumford, a UK-based medical device solutions company, acquired Empelvic for an undisclosed amount. Through this acquisition, Owen Mumford seeks to strategically enhance its pelvic and sexual health portfolio by incorporating Empelvic’s innovative technologies into its existing product range, which includes vaginal dilators and vacuum therapy devices. Empelvic is a Denmark-based company specializing in pelvic floor cushion technology and the manufacture of vaginal dilators.
Major companies operating in the vaginal dilators market are McKesson Corporation, Medline Industries LP, CooperSurgical Inc., MedGyn Products Inc., Femmax, CalExotics, GPC Medical Ltd., AvaCare Medical, Soul Source Inc., Panpac Medical Corporation, Velvi, Amielle, Intimate Rose, Hope&Her, Berman Center, NeuEve LLC, Dr. Berman's Dilators, Vuvatech Inc., Marina Medical Instruments Inc., Bien Aus Pty Ltd.
North America was the largest region in the vaginal dilators market in 2025. The regions covered in the vaginal dilators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vaginal dilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported silicone, plastic, and magnetic components used in vaginal dilators, raising production and retail prices across the market. These impacts are most evident in silicone and magnetic dilator segments, particularly in Asia-Pacific and Europe where many raw materials and finished products are sourced internationally. Higher prices have affected affordability for clinics and home use consumers. However, tariffs have also encouraged local manufacturing and sourcing of medical grade materials, supporting regional production and improving long term supply stability.
The vaginal dilators market research report is one of a series of new reports that provides vaginal dilators market statistics, including vaginal dilators industry global market size, regional shares, competitors with a vaginal dilators market share, detailed vaginal dilators market segments, market trends and opportunities, and any further data you may need to thrive in the vaginal dilators industry. This vaginal dilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vaginal dilators are therapeutic medical tools designed to gently widen the vaginal canal. They come in different sizes and shapes and are used under medical guidance to address specific health conditions and improve comfort.
The primary types of vaginal dilators include silicone vaginal dilators, magnetic vaginal dilators, and others. Silicone vaginal dilators are medical devices manufactured from soft and flexible silicone material and are intended to assist in the gradual stretching of vaginal tissues. These products are distributed through channels such as online platforms, retail pharmacies, and others and are used in applications across hospitals, clinics, and other healthcare settings.
The vaginal dilators market consists of sales of standard dilators, thermal dilators, and custom dilators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vaginal Dilators Market Characteristics
3. Vaginal Dilators Market Supply Chain Analysis
4. Global Vaginal Dilators Market Trends and Strategies
5. Vaginal Dilators Market Analysis of End Use Industries
7. Global Vaginal Dilators Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vaginal Dilators Total Addressable Market (TAM) Analysis for the Market
9. Vaginal Dilators Market Segmentation
10. Vaginal Dilators Market Regional and Country Analysis
11. Asia-Pacific Vaginal Dilators Market
12. China Vaginal Dilators Market
13. India Vaginal Dilators Market
14. Japan Vaginal Dilators Market
15. Australia Vaginal Dilators Market
16. Indonesia Vaginal Dilators Market
17. South Korea Vaginal Dilators Market
18. Taiwan Vaginal Dilators Market
19. South East Asia Vaginal Dilators Market
20. Western Europe Vaginal Dilators Market
21. UK Vaginal Dilators Market
22. Germany Vaginal Dilators Market
23. France Vaginal Dilators Market
24. Italy Vaginal Dilators Market
25. Spain Vaginal Dilators Market
26. Eastern Europe Vaginal Dilators Market
27. Russia Vaginal Dilators Market
28. North America Vaginal Dilators Market
29. USA Vaginal Dilators Market
30. Canada Vaginal Dilators Market
31. South America Vaginal Dilators Market
32. Brazil Vaginal Dilators Market
33. Middle East Vaginal Dilators Market
34. Africa Vaginal Dilators Market
36. Vaginal Dilators Market Competitive Landscape and Company Profiles
37. Vaginal Dilators Market Other Major and Innovative Companies
40. Vaginal Dilators Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vaginal Dilators Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vaginal dilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vaginal dilators? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vaginal dilators market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Silicone Vaginal Dilators; Magnetic Vaginal Dilators; Other Types2) By Distribution Channel: Online Stores; Retail Pharmacies; Other Distribution Channels
3) By Application: Hospitals; Clinic; Other Applications
Subsegments:
1) By Silicone Vaginal Dilators: Standard Silicone Dilators; Textured Silicone Dilators; Multi-Size Silicone Dilators; Heat-Resistant Silicone Dilators2) By Magnetic Vaginal Dilators: Magnetic Therapy Dilators; Magnetic Silicone Dilators; Interchangeable Magnetic Dilators
3) By Other Types: Plastic Vaginal Dilators; Glass Vaginal Dilators; Customizable Vaginal Dilators; Therapeutic Vaginal Dilators
Companies Mentioned: McKesson Corporation; Medline Industries LP ; CooperSurgical Inc.; MedGyn Products Inc.; Femmax; CalExotics; GPC Medical Ltd.; AvaCare Medical; Soul Source Inc.; Panpac Medical Corporation; Velvi; Amielle; Intimate Rose; Hope&Her; Berman Center; NeuEve LLC; Dr. Berman's Dilators; Vuvatech Inc.; Marina Medical Instruments Inc.; Bien Aus Pty Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vaginal Dilators market report include:- McKesson Corporation
- Medline Industries LP
- CooperSurgical Inc.
- MedGyn Products Inc.
- Femmax
- CalExotics
- GPC Medical Ltd.
- AvaCare Medical
- Soul Source Inc.
- Panpac Medical Corporation
- Velvi
- Amielle
- Intimate Rose
- Hope&Her
- Berman Center
- NeuEve LLC
- Dr. Berman's Dilators
- Vuvatech Inc.
- Marina Medical Instruments Inc.
- Bien Aus Pty Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 27.39 Billion |
| Forecasted Market Value ( USD | $ 37.66 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
